Bitcoin Falls Below This Key Level Following Jobless Claims Data; BNB Becomes Top Loser

Bitcoin (CRYPTO: BTC) moved lower, with the cryptocurrency prices trading below the $37,000 level on Wednesday. Ethereum (CRYPTO: ETH), meanwhile, recorded gains, trading above the key $2,000 mark this morning.

Bitcoin (CRYPTO: BTC) moved lower, with the cryptocurrency prices trading below the $37,000 level on Wednesday.

Ethereum (CRYPTO: ETH), meanwhile, recorded gains, trading above the key $2,000 mark this morning.

FTX Token (CRYPTO: FTT) was the top gainer over the prior 24 hours, while BNB (CRYPTO: BNB) turned out to be the biggest loser.

U.S. initial jobless claims declined by 24,000 to 209,000 on the week ending Nov. 18, compared to market expectations of 225,000.

At the time of writing, the global crypto market cap fell to $1.39 trillion, recording a 24-hour decline of 1.7%. BTC was trading lower by 1.7% at $36,554 while ETH rose by around 0.5% to $2,012 on Wednesday.

Here are the top ten crypto gainers and losers over the past 24 hours:

Gainers

 

FTX Token (CRYPTO: FTT)
Price: $4.15
24-hour gain: 37%

Blur (CRYPTO: BLUR)
Price: $0.4503
24-hour gain: 25.2%

dYdX (ethDYDX) (CRYPTO: ETHDYDX)
Price: $3.44
24-hour gain: 12.2%

Klaytn (CRYPTO: KLAY)
Price: $0.1938
24-hour gain: 8%

Uniswap (CRYPTO: UNI)
Price: $5.36
24-hour gain: 5.1%

Losers

 

BNB (CRYPTO: BNB)
Price: $233.19
24-hour drop: 10.2%

NEAR Protocol (CRYPTO: NEAR)
Price: $1.78
24-hour drop: 7.8%

Gala (CRYPTO: GALA)
Price: $0.02346
24-hour drop: 7.7%

Avalanche (CRYPTO: AVAX)
Price: $20.13
24-hour drop: 7.7%

PancakeSwap (CRYPTO: CAKE)
Price: $2.38
24-hour drop: 7.5%

Read This Next: Top 4 Materials Stocks That May Plunge This Quarter

Total
0
Shares
Related Posts
Read More

MangoRx Introduces “MOJO” Pharmaceutical Compounded Formula Featuring Enclomiphene Citrate And Pregnenolone For Treatment Of Low Testosterone And Male Hormone Imbalances; Sold Exclusively On MangoRx’s Website On A Subscription Basis At A Price Of $199…

MOJO to be offered as an Oral Dissolvable Tablet (ODT) marketed to younger male demographic as an alternative to PRIME Testosterone Replacement Therapy (TRT)Dallas, Texas, June 04, 2024 (GLOBE NEWSWIRE) --

MGRX